| ■ 영문 제목 : Global Rivaroxaban API Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K03384 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 125 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 화학&재료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 리바록사반 API의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (순도 ≧ 98%, 순도 < 98%)와 용도별 시장규모 (리바록사반 정제, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 리바록사반 API 시장 점유율 - 지역별 리바록사반 API 시장규모 - 주요지역의 종류별 시장규모 (순도 ≧ 98%, 순도 < 98%) - 주요지역의 용도별 시장규모 (리바록사반 정제, 기타) - 미주의 리바록사반 API 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 리바록사반 API 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 리바록사반 API 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 리바록사반 API 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 리바록사반 API 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Piramal Enterprises Limited, Dr. Reddy's Laboratories, Polpharma S. A., ZCL Chemicals Limited, Interquim SA, Medichem S.A, UQUIFA, Inke, Tecoland, Teva Pharmaceutical Industries Ltd., Symed Labs Limited, Unichem Laboratories Limited, Lupin Ltd, Neuland Laboratories, NG ZIP CHEMICAL INDUSTRIAL, Zhejiang Huahai Pharmaceutial. Co., Ltd. - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Rivaroxaban API will have significant change from previous year. By the most conservative estimates of global Rivaroxaban API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Rivaroxaban API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Purity≥98%
Purity<98%
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Rivaroxaban Tablets
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Piramal Enterprises Limited
Dr. Reddy's Laboratories
Polpharma S. A.
ZCL Chemicals Limited
Interquim SA
Medichem S.A
UQUIFA
Inke
Tecoland
Teva Pharmaceutical Industries Ltd.
Symed Labs Limited
Unichem Laboratories Limited
Lupin Ltd
Neuland Laboratories
NG ZIP CHEMICAL INDUSTRIAL
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Glenmark Pharmaceuticals
Srini Pharmaceuticals Private Limited
Jiangxi Synergy Pharmaceutical Co., Ltd
Lunan Pharmaceutical Group
1 Scope of the Report 2 Executive Summary Table 1. Rivaroxaban API Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Purity≥98% Table 3. Major Players of Purity<98% Table 4. Global Rivaroxaban API Sales by Type (2016-2021) & (Ton) Table 5. Global Rivaroxaban API Sales Market Share by Type (2016-2021) Table 6. Global Rivaroxaban API Revenue by Type (2016-2021) & ($ million) Table 7. Global Rivaroxaban API Revenue Market Share by Type (2016-2021) Table 8. Global Rivaroxaban API Sale Price by Type (2016-2021) Table 9. Global Rivaroxaban API Sales by Application (2016-2021) & (Ton) Table 10. Global Rivaroxaban API Sales Market Share by Application (2016-2021) Table 11. Global Rivaroxaban API Value by Application (2016-2021) Table 12. Global Rivaroxaban API Revenue Market Share by Application (2016-2021) Table 13. Global Rivaroxaban API Sale Price by Application (2016-2021) Table 14. Global Rivaroxaban API Sales by Company (2019-2021) & (Ton) Table 15. Global Rivaroxaban API Sales Market Share by Company (2019-2021) Table 16. Global Rivaroxaban API Revenue by Company (2019-2021) ($ Millions) Table 17. Global Rivaroxaban API Revenue Market Share by Company (2019-2021) Table 18. Global Rivaroxaban API Sale Price by Company (2019-2021) Table 19. Key Manufacturers Rivaroxaban API Producing Area Distribution and Sales Area Table 20. Players Rivaroxaban API Products Offered Table 21. Rivaroxaban API Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Rivaroxaban API Sales by Region (2016-2021) (Ton) Table 25. Global Rivaroxaban API Sales Market Share by Region (2016-2021) Table 26. Global Rivaroxaban API Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Rivaroxaban API Revenue Market Share by Region (2016-2021) Table 28. Americas Rivaroxaban API Sales by Country (2016-2021) & (Ton) Table 29. Americas Rivaroxaban API Sales Market Share by Country (2016-2021) Table 30. Americas Rivaroxaban API Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Rivaroxaban API Revenue Market Share by Country (2016-2021) Table 32. Americas Rivaroxaban API Sales by Type (2016-2021) & (Ton) Table 33. Americas Rivaroxaban API Sales Market Share by Type (2016-2021) Table 34. Americas Rivaroxaban API Sales by Application (2016-2021) & (Ton) Table 35. Americas Rivaroxaban API Sales Market Share by Application (2016-2021) Table 36. APAC Rivaroxaban API Sales by Region (2016-2021) & (Ton) Table 37. APAC Rivaroxaban API Sales Market Share by Region (2016-2021) Table 38. APAC Rivaroxaban API Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Rivaroxaban API Revenue Market Share by Region (2016-2021) Table 40. APAC Rivaroxaban API Sales by Type (2016-2021) & (Ton) Table 41. APAC Rivaroxaban API Sales Market Share by Type (2016-2021) Table 42. APAC Rivaroxaban API Sales by Application (2016-2021) & (Ton) Table 43. APAC Rivaroxaban API Sales Market Share by Application (2016-2021) Table 44. Europe Rivaroxaban API Sales by Country (2016-2021) & (Ton) Table 45. Europe Rivaroxaban API Sales Market Share by Country (2016-2021) Table 46. Europe Rivaroxaban API Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Rivaroxaban API Revenue Market Share by Country (2016-2021) Table 48. Europe Rivaroxaban API Sales by Type (2016-2021) & (Ton) Table 49. Europe Rivaroxaban API Sales Market Share by Type (2016-2021) Table 50. Europe Rivaroxaban API Sales by Application (2016-2021) & (Ton) Table 51. Europe Rivaroxaban API Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Rivaroxaban API Sales by Country (2016-2021) & (Ton) Table 53. Middle East & Africa Rivaroxaban API Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Rivaroxaban API Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Rivaroxaban API Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Rivaroxaban API Sales by Type (2016-2021) & (Ton) Table 57. Middle East & Africa Rivaroxaban API Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Rivaroxaban API Sales by Application (2016-2021) & (Ton) Table 59. Middle East & Africa Rivaroxaban API Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Rivaroxaban API Table 61. Key Application and Potential Industries of Rivaroxaban API Table 62. Key Challenges of Rivaroxaban API Table 63. Key Trends of Rivaroxaban API Table 64. Rivaroxaban API Distributors List Table 65. Rivaroxaban API Customer List Table 66. Global Rivaroxaban API Sales Forecast by Region (2021-2026) & (Ton) Table 67. Global Rivaroxaban API Consumption Market Forecast by Region Table 68. Global Rivaroxaban API Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Rivaroxaban API Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Rivaroxaban API Sales Forecast by Country (2021-2026) & (Ton) Table 71. Americas Rivaroxaban API Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Rivaroxaban API Sales Forecast by Region (2021-2026) & (Ton) Table 73. APAC Rivaroxaban API Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Rivaroxaban API Sales Forecast by Country (2021-2026) & (Ton) Table 75. Europe Rivaroxaban API Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Rivaroxaban API Sales Forecast by Country (2021-2026) & (Ton) Table 77. Middle East & Africa Rivaroxaban API Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Rivaroxaban API Sales Forecast by Type (2021-2026) & (Ton) Table 79. Global Rivaroxaban API Sales Market Share Forecast by Type (2021-2026) Table 80. Global Rivaroxaban API Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Rivaroxaban API Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Rivaroxaban API Sales Forecast by Application (2021-2026) & (Ton) Table 83. Global Rivaroxaban API Sales Market Share Forecast by Application (2021-2026) Table 84. Global Rivaroxaban API Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Rivaroxaban API Revenue Market Share Forecast by Application (2021-2026) Table 86. Piramal Enterprises Limited Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 87. Piramal Enterprises Limited Rivaroxaban API Product Offered Table 88. Piramal Enterprises Limited Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 89. Piramal Enterprises Limited Main Business Table 90. Piramal Enterprises Limited Latest Developments Table 91. Dr. Reddy's Laboratories Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 92. Dr. Reddy's Laboratories Rivaroxaban API Product Offered Table 93. Dr. Reddy's Laboratories Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 94. Dr. Reddy's Laboratories Main Business Table 95. Dr. Reddy's Laboratories Latest Developments Table 96. Polpharma S. A. Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 97. Polpharma S. A. Rivaroxaban API Product Offered Table 98. Polpharma S. A. Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 99. Polpharma S. A. Main Business Table 100. Polpharma S. A. Latest Developments Table 101. ZCL Chemicals Limited Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 102. ZCL Chemicals Limited Rivaroxaban API Product Offered Table 103. ZCL Chemicals Limited Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 104. ZCL Chemicals Limited Main Business Table 105. ZCL Chemicals Limited Latest Developments Table 106. Interquim SA Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 107. Interquim SA Rivaroxaban API Product Offered Table 108. Interquim SA Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 109. Interquim SA Main Business Table 110. Interquim SA Latest Developments Table 111. Medichem S.A Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 112. Medichem S.A Rivaroxaban API Product Offered Table 113. Medichem S.A Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 114. Medichem S.A Main Business Table 115. Medichem S.A Latest Developments Table 116. UQUIFA Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 117. UQUIFA Rivaroxaban API Product Offered Table 118. UQUIFA Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 119. UQUIFA Main Business Table 120. UQUIFA Latest Developments Table 121. Inke Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 122. Inke Rivaroxaban API Product Offered Table 123. Inke Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 124. Inke Main Business Table 125. Inke Latest Developments Table 126. Tecoland Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 127. Tecoland Rivaroxaban API Product Offered Table 128. Tecoland Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 129. Tecoland Main Business Table 130. Tecoland Latest Developments Table 131. Teva Pharmaceutical Industries Ltd. Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 132. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Product Offered Table 133. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 134. Teva Pharmaceutical Industries Ltd. Main Business Table 135. Teva Pharmaceutical Industries Ltd. Latest Developments Table 136. Symed Labs Limited Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 137. Symed Labs Limited Rivaroxaban API Product Offered Table 138. Symed Labs Limited Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 139. Symed Labs Limited Main Business Table 140. Symed Labs Limited Latest Developments Table 141. Unichem Laboratories Limited Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 142. Unichem Laboratories Limited Rivaroxaban API Product Offered Table 143. Unichem Laboratories Limited Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 144. Unichem Laboratories Limited Main Business Table 145. Unichem Laboratories Limited Latest Developments Table 146. Lupin Ltd Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 147. Lupin Ltd Rivaroxaban API Product Offered Table 148. Lupin Ltd Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 149. Lupin Ltd Main Business Table 150. Lupin Ltd Latest Developments Table 151. Neuland Laboratories Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 152. Neuland Laboratories Rivaroxaban API Product Offered Table 153. Neuland Laboratories Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 154. Neuland Laboratories Main Business Table 155. Neuland Laboratories Latest Developments Table 156. NG ZIP CHEMICAL INDUSTRIAL Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 157. NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Product Offered Table 158. NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 159. NG ZIP CHEMICAL INDUSTRIAL Main Business Table 160. NG ZIP CHEMICAL INDUSTRIAL Latest Developments Table 161. Zhejiang Huahai Pharmaceutial. Co., Ltd. Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 162. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Product Offered Table 163. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 164. Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business Table 165. Zhejiang Huahai Pharmaceutial. Co., Ltd. Latest Developments Table 166. Glenmark Pharmaceuticals Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 167. Glenmark Pharmaceuticals Rivaroxaban API Product Offered Table 168. Glenmark Pharmaceuticals Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 169. Glenmark Pharmaceuticals Main Business Table 170. Glenmark Pharmaceuticals Latest Developments Table 171. Srini Pharmaceuticals Private Limited Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 172. Srini Pharmaceuticals Private Limited Rivaroxaban API Product Offered Table 173. Srini Pharmaceuticals Private Limited Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 174. Srini Pharmaceuticals Private Limited Main Business Table 175. Srini Pharmaceuticals Private Limited Latest Developments Table 176. Jiangxi Synergy Pharmaceutical Co., Ltd Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 177. Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Product Offered Table 178. Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 179. Jiangxi Synergy Pharmaceutical Co., Ltd Main Business Table 180. Jiangxi Synergy Pharmaceutical Co., Ltd Latest Developments Table 181. Lunan Pharmaceutical Group Basic Information, Rivaroxaban API Manufacturing Base, Sales Area and Its Competitors Table 182. Lunan Pharmaceutical Group Rivaroxaban API Product Offered Table 183. Lunan Pharmaceutical Group Rivaroxaban API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 184. Lunan Pharmaceutical Group Main Business Table 185. Lunan Pharmaceutical Group Latest Developments List of Figures Figure 1. Picture of Rivaroxaban API Figure 2. Rivaroxaban API Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Rivaroxaban API Sales Growth Rate 2016-2026 (Ton) Figure 7. Global Rivaroxaban API Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Rivaroxaban API Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Purity≥98% Figure 10. Product Picture of Purity<98% Figure 11. Global Rivaroxaban API Sales Market Share by Type in 2020 Figure 12. Global Rivaroxaban API Revenue Market Share by Type (2016-2021) Figure 13. Rivaroxaban API Consumed in Rivaroxaban Tablets Figure 14. Global Rivaroxaban API Market: Rivaroxaban Tablets (2016-2021) & (Ton) Figure 15. Rivaroxaban API Consumed in Others Figure 16. Global Rivaroxaban API Market: Others (2016-2021) & (Ton) Figure 17. Global Rivaroxaban API Sales Market Share by Application (2016-2021) Figure 18. Global Rivaroxaban API Revenue Market Share by Application in 2020 Figure 19. Rivaroxaban API Revenue Market by Company in 2020 ($ Million) Figure 20. Global Rivaroxaban API Revenue Market Share by Company in 2020 Figure 21. Global Rivaroxaban API Sales Market Share by Regions (2016-2021) Figure 22. Global Rivaroxaban API Revenue Market Share by Region in 2020 Figure 23. Americas Rivaroxaban API Sales 2016-2021 (Ton) Figure 24. Americas Rivaroxaban API Revenue 2016-2021 ($ Millions) Figure 25. APAC Rivaroxaban API Sales 2016-2021 (Ton) Figure 26. APAC Rivaroxaban API Revenue 2016-2021 ($ Millions) Figure 27. Europe Rivaroxaban API Sales 2016-2021 (Ton) Figure 28. Europe Rivaroxaban API Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Rivaroxaban API Sales 2016-2021 (Ton) Figure 30. Middle East & Africa Rivaroxaban API Revenue 2016-2021 ($ Millions) Figure 31. Americas Rivaroxaban API Sales Market Share by Country in 2020 Figure 32. Americas Rivaroxaban API Revenue Market Share by Country in 2020 Figure 33. Americas Rivaroxaban API Sales Market Share by Type in 2020 Figure 34. Americas Rivaroxaban API Sales Market Share by Application in 2020 Figure 35. United States Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Rivaroxaban API Sales Market Share by Region in 2020 Figure 40. APAC Rivaroxaban API Revenue Market Share by Regions in 2020 Figure 41. APAC Rivaroxaban API Sales Market Share by Type in 2020 Figure 42. APAC Rivaroxaban API Sales Market Share by Application in 2020 Figure 43. China Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 47. India Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Rivaroxaban API Sales Market Share by Country in 2020 Figure 50. Europe Rivaroxaban API Revenue Market Share by Country in 2020 Figure 51. Europe Rivaroxaban API Sales Market Share by Type in 2020 Figure 52. Europe Rivaroxaban API Sales Market Share by Application in 2020 Figure 53. Germany Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 54. France Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Rivaroxaban API Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Rivaroxaban API Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Rivaroxaban API Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Rivaroxaban API Sales Market Share by Application in 2020 Figure 62. Egypt Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Rivaroxaban API Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 리바록사반 API 시장예측 2021년-2026년] (코드 : LPI-2201K03384) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 리바록사반 API 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |